Announcing Wide-Ranging ZD4054 Phase III Development Program For
Medical News Today – Announcing Wide-Ranging ZD4054 Phase III Development Program For Prostate Cancer Treatment Main Category: Prostate / Prostate Cancer News Article Date: 27 Sep 2007 – 9:00 PDT email to a friend printer friendly view / write opinions rate article
Source: www.medicalnewstoday.com

Daily checkup
Lexington Herald-Leader – A prostate cancer treatment often given to men with aggressive forms of the disease might increase tumor cells’ ability to spread through the body, according to a study published in yesterday’s issue of Cancer Research. The research, led by David
Source: www.kentucky.com

Dendreon’s Dilemma
Forbes – Shares of Seattle biotech Dendreon plunged more than 55% in early trading Wednesday, to just over $7, after the U.S. Food and Drug Administration rejected the company’s main product, Provenge. Dendreon may face years of work to get the prostate
Source: www.forbes.com

Lindsay steps down as Ardana chief
Edinburgh News – has played a major role in steering Ardana through key stages of its product pipeline development – said she was confident Ardana would realise its global commercial potential, particularly with lead product Teverelix, its prostate cancer treatment
Source: edinburghnews.scotsman.com

Prostate Cancer Treatment May Have Downside
HealthScout – (Ivanhoe Newswire) — A common treatment given to men who suffer from aggressive prostate cancer may actually be helping those cancers migrate to other parts of the body. Researchers from Johns Hopkins University came to that conclusion after
Source: www.healthscout.com

diet & Health : Children & Women
Food Consumer – A popular prostate cancer treatment called androgen deprivation therapy may encourage prostate cancer cells to produce a protein that makes them more likely to spread throughout the body, a new study by Johns Hopkins researchers suggests. Oct 3, 2007
Source: foodconsumer.org

Daily checkup
Lexington Herald-Leader – A prostate cancer treatment often given to men with aggressive forms of the disease might increase tumor cells’ ability to spread through the body, according to a study published in yesterday’s issue of Cancer Research. The research, led by David
Source: www.kentucky.com

Dendreon’s Dilemma
Forbes – Shares of Seattle biotech Dendreon plunged more than 55% in early trading Wednesday, to just over $7, after the U.S. Food and Drug Administration rejected the company’s main product, Provenge. Dendreon may face years of work to get the prostate
Source: www.forbes.com

Lindsay steps down as Ardana chief
Edinburgh News – has played a major role in steering Ardana through key stages of its product pipeline development – said she was confident Ardana would realise its global commercial potential, particularly with lead product Teverelix, its prostate cancer treatment
Source: edinburghnews.scotsman.com

diet & Health : Children & Women
Food Consumer – A popular prostate cancer treatment called androgen deprivation therapy may encourage prostate cancer cells to produce a protein that makes them more likely to spread throughout the body, a new study by Johns Hopkins researchers suggests. Oct 3, 2007
Source: foodconsumer.org

Visible Bodies
Slate – Prostate cancer treatment reduced penis length by 40 percent in a Turkish study. The treatment was “androgen suppression plus radiation”; the result over 18 months was a reduction in average “stretched penile length” from 5.6 to 3.4 inches . Authors
Source: www.slate.com

Implants are another option for men with E.D.
San Antonio Express News – Gaery Goodman and his wife have shared 26 years of marriage, a marriage strained by the after effects of his prostate cancer treatment. Surgery and radiation caused impotence that pills and shots couldn’t cure. “I won’t say you’re
Source: www.mysanantonio.com

Health Institutions Fail to Connect with ”Grateful Patients
Forbes – include The Salvation Army, American Red Cross, Rescue Missions, Food Banks, Roswell Park Cancer Institute, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, state Sheriffs’ Associations, Habitat for Humanity affiliates, Prostate Cancer
Source: www.forbes.com

Bond of Bereavement
Washington Post – Help him up!” said Jonathan Burks, 17, of Upper Marlboro , who came to camp with his brother, James, 19, because of the recent death of their father from prostate cancer. “Push him up! Help him get up!” A dozen hands sent David over the wall as other
Source: www.washingtonpost.com

GPC Takes a Pit Stop
Motley Fool – The company was trying to get Satraplatin approved to treat hormone-refractory prostate cancer in patients whose prior chemotherapy has failed. Because of the lack of treatments for patients with late-stage prostate cancer, the FDA had given
Source: www.fool.com

Hominy & Hash
American Reporter – In an article by Jamie Stengle of the Associated Press we learn “that neither soy nor the soy component isoflavone reduced symptoms of menopause, such as ‘hot flashes,’ and that isoflavones don’t help uterine or prostate cancer. “Based on it’s
Source: www.american-reporter.com

Medical literacy may help save lives
Boston Globe – Prostate cancer affects 1 in 6 men, making it the most common non-skin cancer in the United States. For men who have cancer solely confined to the prostate, surgery is a standard treatment option. Before going to the operating room, however, men
Source: www.boston.com